Venture • Digital Media

Eight Roads Invests In Port

On January 1, 2016, private equity firm Eight Roads invested in digital media company Port

Investment Context
  • This is Eight Roads’ 1st transaction in the Digital Media sector.
  • This is Eight Roads’ 6th transaction in Japan.

Explore All 38 Venture Digital Media Deals - Search the Database Free


Investment Summary

Date January 1, 2016
Target Port
Sector Digital Media
Investor(s) Eight Roads
Deal Type Venture

Target Company

Port

Tokyo, Japan
Port operates several vertical media specialized in various fields and develop content marketing that meets user needs. Since it is a vertical media, the content that meets the needs of the user and the advertising that promotes it are very effective, and the user's actions within the media become active, so a lot of behavior data can be obtained. Port was founded i 2018 and is based in Tokyo, Japan.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Eight Roads

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1969
PE ASSETS 11.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.


Deal Context for Investor #
Overall 119 of 293
Sector: Digital Media 1 of 1
Type: Venture 99 of 266
Country: Japan 6 of 25
Year: 2016 6 of 22
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-01 Promentis Pharmaceuticals

Milwaukee, Wisconsin, United States

Promentis Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of first-in-class therapies to treat central nervous system disorders of System XC. Promentis Pharmaceuticals was founded in 2007 and is based in Milwaukee, Wisconsin.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-07 QuanCheng

Shanghai, China

QuanCheng is a SaaS corporate expense management startup, specializing in corporate expense management and vendor management. QuanCheng was founded in 2013 and is based in Shanghai, China.

Buy -

Explore Related M&A Activity